The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Efficacy and safety of albumin-bound docetaxel vs. docetaxel in patients with previously treated advanced gastric or gastroesophageal junction adenocarcinoma: A multicenter, randomized, phase II study.
 
Zhiqiang Wang
No Relationships to Disclose
 
Dongliang Chen
No Relationships to Disclose
 
Hongli Li
No Relationships to Disclose
 
Mudan Yang
No Relationships to Disclose
 
Rongbo Lin
No Relationships to Disclose
 
Ying Cheng
No Relationships to Disclose
 
Zhiwei Li
No Relationships to Disclose
 
Xiwen Huang
No Relationships to Disclose
 
Wei Wang
No Relationships to Disclose
 
Hui Li
No Relationships to Disclose
 
Hao Liu
No Relationships to Disclose
 
Youguo Dai
No Relationships to Disclose
 
Jufeng Wang
No Relationships to Disclose
 
Xin Zhao
No Relationships to Disclose
 
Yan Yang
No Relationships to Disclose
 
Xiujuan Qu
No Relationships to Disclose
 
Jun Zhao
No Relationships to Disclose
 
Zhe Zhang
Employment - CSPC ZhongQi Pharmaceutical Technology
 
Yanyan Zeng
Employment - CSPC ZhongQi Pharmaceutical Technology
 
Rui-Hua Xu
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; BeiGene; CPPC; Hengrui Pharm; Hutchison MediPharma; Innovent Biologics; Junshi Pharmaceuticals; Keymed Biosience; Merck Serono; MSD; QiLu Pharmaceutical; Roche